Articles with public access mandates - Olaf StuveLearn more
Not available anywhere: 14
Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: in search of biomarkers
S Alvermann, C Hennig, O Stüve, H Wiendl, M Stangel
JAMA neurology 71 (7), 905-912, 2014
Mandates: German Research Foundation
Immunopathogenesis of neuromyelitis optica
M Levy, B Wildemann, S Jarius, B Arellano, S Sasidharan, MS Weber, ...
Advances in immunology 121, 213-242, 2014
Mandates: Doris Duke Charitable Foundation
Teriflunomide for treatment of multiple sclerosis
C Warnke, G Meyer Zu Hörste, T Menge, O Stüve, HP Hartung, H Wiendl, ...
Der Nervenarzt 84, 724-731, 2013
Mandates: German Research Foundation
Central nervous system infections–a potential complication of systemic immunotherapy
B Hemmer, E Frohman, HP Hartung, O Stüve
Current opinion in neurology 19 (3), 271-276, 2006
Mandates: German Research Foundation
Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates
D Dubey, BC Kieseier, HP Hartung, B Hemmer, WA Miller-Little, O Stuve
Expert review of clinical immunology 11 (1), 93-108, 2015
Mandates: German Research Foundation
Emerging drugs for primary progressive multiple sclerosis
RN Narayan, T Forsthuber, O Stüve
Expert Opinion on Emerging Drugs 23 (2), 97-110, 2018
Mandates: US National Institutes of Health
Managing disability in progressive multiple sclerosis
D Dubey, P Sguigna, O Stüve
Current treatment options in neurology 18, 1-13, 2016
Mandates: US Department of Veterans Affairs
Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis
D Dubey, CA Cano, O Stüve
Current opinion in neurology 29 (3), 272-277, 2016
Mandates: US Department of Veterans Affairs
Will biomarkers determine what is next in multiple sclerosis? Biomarkers in multiple sclerosis
O Stuve, MK Racke
JAMA NEUROLOGY 73 (5), 496-497, 2016
Mandates: US Department of Veterans Affairs
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS
R Hussain, S O’Leary, FM Pacheco, TE Zacharias, P Litvak, P Sguigna, ...
Journal of neurology 263, 606-610, 2016
Mandates: US Department of Veterans Affairs
Multiple sclerosis drugs: how much bang for the buck?
O Stüve, GR Cutter
The Lancet Neurology 14 (5), 460-461, 2015
Mandates: US Department of Veterans Affairs
Does natalizumab therapy benefit patients with multiple sclerosis?
O Stüve, GR Cutter
JAMA neurology 71 (8), 945-946, 2014
Mandates: US National Institutes of Health
Teriflunomid zur Behandlung der Multiplen Sklerose.
C Warnke, G Meyer Zu Hörste, T Menge, O Stüve, HP Hartung, H Wiendl, ...
Der Nervenarzt 84 (6), 2013
Mandates: German Research Foundation
(DXT40) Effect of the S1P1/5 Receptor Modulator Ozanimod on Cognitive Processing Speed in Subjects with Relapsing Multiple Sclerosis: Design of the ENLIGHTEN Study.
JV Riolo, L Yang, T Rano, R Zivadinov, LB Krupp, J Calkwood, O Stuve, ...
International Journal of MS Care 22, 2020
Mandates: US Department of Defense, US National Institutes of Health
Available somewhere: 94
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
Mandates: European Commission, Multiple Sclerosis Society of Canada
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review
RA Marrie, S Reingold, J Cohen, O Stuve, M Trojano, PS Sorensen, ...
Multiple Sclerosis Journal 21 (3), 305-317, 2015
Mandates: National Institute of Health and Medical Research, France
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
MS Weber, T Prod'homme, S Youssef, SE Dunn, CD Rundle, L Lee, ...
Nature medicine 13 (8), 935-943, 2007
Mandates: German Research Foundation
Immune surveillance in multiple sclerosis patients treated with natalizumab
O Stüve, CM Marra, KR Jerome, L Cook, PD Cravens, S Cepok, ...
Annals of Neurology: Official Journal of the American Neurological …, 2006
Mandates: German Research Foundation
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview
RA Marrie, J Cohen, O Stuve, M Trojano, PS Sørensen, S Reingold, ...
Multiple Sclerosis Journal 21 (3), 263-281, 2015
Mandates: Canadian Institutes of Health Research, National Institute of Health and …
Factors that influence adherence with disease-modifying therapy in MS
K Treadaway, G Cutter, A Salter, S Lynch, J Simsarian, J Corboy, ...
Journal of neurology 256, 568-576, 2009
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program